Building successful AI projects for patients and healthcare professionals

12 janvier 2026

Aucun chapitre disponible pour le moment

Building successful AI projects for patients and healthcare professionals

00:15 - 00:24
Intervenant 1
Welcome to a special episode of Tech Anatomy, live from Adobe AI Grand Paris.  With me today is Reda Guilla, president of Pfizer France.  Welcome to the show. 
00:25 - 00:27
Intervenant 2
Hi.  Hi, Anka. 
00:27 - 01:13
Intervenant 1
So today, we're going to talk about Pfizer, a leading pharmaceutical company, and the different investments it is making in artificial intelligence.  Artificial intelligence is set to revolutionize everything from drug discovery to patient care, and we will dive deep into the different use cases that you are implementing.  But first of all, across Europe, we see a shifting environment with different regulations coming up, different partnerships, and also rising expectations from health care professionals for really powerful AI tools that change the way they interact with their patients.  For Pfizer, which is a global pharmaceutical company, what type of role do you see the company having today and in the upcoming years in this evolving ecosystem? 
01:13 - 01:42
Intervenant 2
So, Anke, I think we're leaving the Renaissance when it comes to healthcare.  You mentioned AI revolutionizing health care.  This is true.  When you look at the lab, the preclinical development of assets, the research of assets, this is being accelerated thanks to AI.  AI is also revolutionizing the speed of clinical development and the probability of success. 

La suite de la transcription est réservée aux clients Pro

Débloquez la transcription complète, le chat et toutes les fonctionnalités d'analyse avec Polyfact Pro.

Posez une question sur cette vidéo — j'analyse sa transcription pour vous répondre.

Focalisé sur : Building successful AI projects for patients and healthcare professionals